As a diversified global healthcare leader, Sanofi pursue new therapeutic solutions and propose products that respond to the needs of patients.
To respond to major healthcare issues, Sanofi proposes a diversified offer of prescription medicines, consumer healthcare products, generic drugs, vaccines, and animal health products.
With its recent acquisition of Genzyme, Sanofi can now address the needs of patients with rare diseases such as Gaucher's disease, Fabry disease, or Pompe disease.
The following information is solely intended to provide details concerning the activity profile of Group products, and should not be considered as encouraging their prescription or use. The decision to prescribe these products is the responsibility of physicians, who will take into account the benefit-risk ratio with regard to the treatment of specific clinical cases and the registered indications in each country.
Diabetes
Sanofi is committed to improving global diabetes management through its integrated offering of therapies, devices and services.
Sanofi’s mission is to create solutions for currently unmet medical needs. Sanofi employ innovative approaches to attack cancer on all fronts and provide medicines adapted to the diverse profiles of patients.
Protecting and improving human health worldwide is our primary objective. Sanofi thus provides patients with one of the world’s largest ranges of vaccines for the prevention and treatment of diseases.
Sanofi is a global leader in consumer healthcare. Since 2008, with targeted acquisitions, Sanofi has been implementing an important strategy of diversifying. Accelerating growth in consumer healthcare also involves regional development hubs in the US, Europe, Asia-Pacific and Latin America.